Company intelligence / Profile preview

Pace Pharmaceuticals

San Carlos, California, United States

Ownership: Private
Development stage: Other

Overview

Pace Pharmaceuticals is an early-stage drug discovery company developing small molecule therapeutics for rare neurological disorders. The company states that it uses AI to design lower-cost and effective medicines for diseases with significant unmet medical need. Based in San Carlos, California, Pace appears to be a private startup focused on discovery-stage research rather than commercial products. Publicly available information suggests a platform-oriented model centered on computational drug design, but no named clinical pipeline programs were clearly disclosed on the company website.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

2 assets

PAC-832

Preclinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Pace Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pace Pharmaceuticals.

Explore the full profile